Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site
- PMID: 1648738
- PMCID: PMC52079
- DOI: 10.1073/pnas.88.14.6343
Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site
Abstract
Epstein-Barr virus (EBV) expresses six nuclear antigens (EBNAs) and three integral latent membrane proteins (LMPs) in latently infected growth-transformed B lymphoblastoid cell lines (LCLs). In contrast, EBV protein expression in Burkitt lymphoma tissue or in newly established Burkitt lymphoma cell lines is frequently restricted to the EBV genome maintenance protein, EBNA-1. EBNA-1 expression in the absence of other EBNAs and LMP-1 has been an enigma since, in LCLs, all EBNA mRNAs are processed from a single transcript. We now show that the basis for restricted EBV expression in Burkitt lymphoma cells is selective EBNA-1 mRNA transcription from a hitherto unrecognized promoter that is 50 kb closer to the EBNA-1-encoding exon than previously described EBNA-1 promoters. Infected cells with EBNA-1-restricted expression could preferentially persist in vivo in the face of EBV-immune T-cell responses, which are frequently directed against other EBNAs and are also dependent on LMP-1 expression.
Similar articles
-
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6550-4. doi: 10.1073/pnas.88.15.6550. Proc Natl Acad Sci U S A. 1991. PMID: 1713681 Free PMC article.
-
Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.Blood. 1992 Jul 15;80(2):459-69. Blood. 1992. PMID: 1378321
-
Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.Int J Cancer. 1993 Feb 20;53(4):621-7. doi: 10.1002/ijc.2910530416. Int J Cancer. 1993. PMID: 8382194
-
T cell recognition of Epstein-Barr virus associated lymphomas.Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review.
-
Immortalizing genes of Epstein-Barr virus.Adv Virus Res. 1991;40:19-55. doi: 10.1016/s0065-3527(08)60276-6. Adv Virus Res. 1991. PMID: 1659776 Review.
Cited by
-
Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.J Virol. 2013 Mar;87(5):2882-94. doi: 10.1128/JVI.03003-12. Epub 2012 Dec 26. J Virol. 2013. PMID: 23269792 Free PMC article.
-
The expression and function of Epstein-Barr virus encoded latent genes.Mol Pathol. 2000 Oct;53(5):238-47. doi: 10.1136/mp.53.5.238. Mol Pathol. 2000. PMID: 11091847 Free PMC article. Review.
-
Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.J Virol. 2005 Aug;79(16):10709-17. doi: 10.1128/JVI.79.16.10709-10717.2005. J Virol. 2005. PMID: 16051863 Free PMC article.
-
Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.J Virol. 1995 Jan;69(1):231-8. doi: 10.1128/JVI.69.1.231-238.1995. J Virol. 1995. PMID: 7983714 Free PMC article.
-
Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV.J Clin Pathol. 1996 Nov;49(11):897-902. doi: 10.1136/jcp.49.11.897. J Clin Pathol. 1996. PMID: 8944608 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous